Waters Corp WAT

$470.90 -4.62 (-0.97%)

Valuation

Market cap
46,718,888,000
Revenue TTM
$3,165,290,000
Net income TTM
$642,630,000
P/E (trailing)
33.15
P/E (forward)
32.55
Profit margin
20.30%
Debt to equity
0.00

Trading

Volume
651,900
Avg volume
870,560
Day's range
$470.65 – $483.33
Shares out
98,248,000
Stochastic %K
67%
Beta
1.16
Analysts
Strong Buy
Price target
$503.41

Price

Company profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services...

Show more

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
508 478 2000
Website
https://www.waters.com
Address
34 Maple Street, Milford, United States

Latest news

Stocktwits

Stocktwits52wHighs Nov 11, 5:16 PM
$WAT printed a new 52-week high today
0 replies
Rayvio_News_Filter Nov 10, 1:07 PM
$WAT 🏥 Waters Corporation received FDA 510(k) clearance for the BD OneFlow LST and BD OneFlow B-CLPD T1 flow cytometry tests for leukemia and lymphoma, enabling U.S. commercialization. Selected from hundreds of headlines
0 replies
GTA_Terminal Nov 7, 7:51 AM
Dark pool check on $WAT: what traded off the exchanges this session. Price barely moved (+1.0%), which is what you'd expect if somebody big is building or unwinding a position quietly. Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days: https://globaltradersacademy.com/start-trial?a=stocktwits&sym=WAT&utm_source=stocktwits&utm_medium=social&utm_campaign=trial&utm_content=WAT Read the full article for the full details: https://globaltradersacademy.com/articles/dark-pool-check-waters-wat?utm_source=stocktwits&utm_medium=social
0 replies
shoc24 Nov 3, 2:18 PM
$WAT reported earnings this morning before the open and beat EPS estimates: $4.10 adjusted EPS vs $4.00 expected, according to Stock Meadow.
0 replies
EarningsInsider Nov 3, 2:17 PM
https://www.marketbeat.com/earnings/reports/2026-11-3-waters-co-stock/ $WAT Waters Earnings Transcript
0 replies
StocktwitsEarnings Nov 3, 12:45 PM
$WAT Q3 '26 Earnings Results & Recap Waters raised FY2026 guidance to reported revenue of $6.48B, organic constant-currency growth of 9.1%9.7%, and adjusted EPS of $14.60$14.70; Q4 reported revenue is expected to be in the range of $1.8B.
0 replies
flychicken1991 Nov 3, 11:08 AM
$WAT Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results. Impact: Positive (84%). faces upward price pressure because results above company guidance and a higher annual outlook support higher forward earnings estimates; acquisition costs and slower projected fourth-quarter EPS growth could cap the gain. Source and what to watch next: https://nimpact.tech/newsimpact/news/0a9acb1af04d5e51/wat-waters-corporation-nyse-wat-reports-third-quarter-2026-financial-res?utm_source=stocktwits&utm_medium=story_url
0 replies
Estimize Nov 3, 11:06 AM
$WAT reported - EPS and - revenue for Q3. http://www.estimize.com/intro/wat?chart=historical&metric_name=eps&utm_content=WAT&utm_medium=act
0 replies